Large paracetamol overdose-Higher dose acetylcysteine is required.

Area of Science:

• Toxicology
• Pharmacology
• Hepatology

Background:

• Paracetamol (acetaminophen) poisoning is a global health issue.
• Current acetylcysteine (NAC) treatment protocols may be suboptimal for very high paracetamol doses.
• Increased toxicity is observed even with prompt NAC, especially above 300 mg/L treatment threshold.

Purpose of the Study:

• To review current evidence on paracetamol poisoning management.
• To explore the potential for intensified acetylcysteine (NAC) dosing.
• To discuss new biomarkers for early risk identification in paracetamol toxicity.

Main Methods:

• Literature review of recent case series and clinical trial evidence.
• Analysis of emerging biomarkers for liver injury prediction.
• Discussion of proposed intensified NAC dosing regimens.

Main Results:

• High-dose paracetamol can cause toxicity despite standard NAC therapy.
• Shorter NAC dosing regimens may allow for treatment intensification with acceptable adverse drug reaction (ADR) rates.
• Novel biomarkers may aid in identifying high-risk patients needing escalated treatment.

Conclusions:

• Optimizing acetylcysteine (NAC) dosing is crucial for severe paracetamol poisoning.
• Intensified NAC therapy, guided by biomarkers and clinical data, warrants further investigation.
• Proposed intensified treatment strategies require clinical trial validation.